168 related articles for article (PubMed ID: 1916323)
1. Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
Larsen M; Dalgaard P; Lund-Andersen H
Graefes Arch Clin Exp Ophthalmol; 1991; 229(4):350-7. PubMed ID: 1916323
[TBL] [Abstract][Full Text] [Related]
2. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
Larsen M
Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
[TBL] [Abstract][Full Text] [Related]
3. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
Engler CB; Sander B; Larsen M; Dalgaard P; Lund-Andersen H
Acta Ophthalmol (Copenh); 1994 Dec; 72(6):655-62. PubMed ID: 7747570
[TBL] [Abstract][Full Text] [Related]
4. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
Engler CB; Sander B; Larsen M; Koefoed P; Parving HH; Lund-Andersen H
Acta Ophthalmol (Copenh); 1994 Dec; 72(6):663-7. PubMed ID: 7747571
[TBL] [Abstract][Full Text] [Related]
5. Blood-retina barrier permeability is independent of trace substance lipid solubility in retinitis pigmentosa and in the healthy eye.
Larsen M; Engler CB; Haim M; Lund-Andersen H
Int Ophthalmol; 1997-1998; 21(4):229-34. PubMed ID: 9700011
[TBL] [Abstract][Full Text] [Related]
6. The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema.
Moldow B; Sander B; Larsen M; Engler C; Li B; Rosenberg T; Lund-Andersen H
Graefes Arch Clin Exp Ophthalmol; 1998 Dec; 236(12):881-9. PubMed ID: 9865617
[TBL] [Abstract][Full Text] [Related]
7. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.
Lobo CL; Bernardes RC; Santos FJ; Cunha-Vaz JG
Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960
[TBL] [Abstract][Full Text] [Related]
8. Anterior chamber and vitreous fluorescein kinetics in normal and diabetic subjects.
Knudsen LL; Nielsen-Kudsk F
Acta Ophthalmol Scand; 1998 Aug; 76(4):396-400. PubMed ID: 9716323
[TBL] [Abstract][Full Text] [Related]
9. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy.
Yoshida A; Kojima M; Ogasawara H; Ishiko S
Ophthalmology; 1991 Aug; 98(8):1266-71. PubMed ID: 1923365
[TBL] [Abstract][Full Text] [Related]
10. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects.
Knudsen LL; Olsen T; Nielsen-Kudsk F
Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478
[TBL] [Abstract][Full Text] [Related]
11. [Permeability of the blood-ocular barrier in diabetics without retinopathy].
Yoshida A; Kojima M; Nara Y; Ohta I
Nippon Ganka Gakkai Zasshi; 1988 Jun; 92(6):1016-20. PubMed ID: 3189073
[No Abstract] [Full Text] [Related]
12. Studies on the technique of vitreous fluorophotometry.
Zeimer RC; Cunha-Vaz JG; Johnson ME
Invest Ophthalmol Vis Sci; 1982 May; 22(5):668-74. PubMed ID: 7076410
[TBL] [Abstract][Full Text] [Related]
13. The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways.
Araie M; Maurice DM
Exp Eye Res; 1991 Jan; 52(1):27-39. PubMed ID: 1714398
[TBL] [Abstract][Full Text] [Related]
14. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB.
Moldow B; Sander B; Larsen M; Lund-Andersen H
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1770-5. PubMed ID: 10393047
[TBL] [Abstract][Full Text] [Related]
15. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
Retina; 1987; 7(3):170-6. PubMed ID: 3423432
[TBL] [Abstract][Full Text] [Related]
16. A scanning ocular spectrofluorophotometer.
McLaren JW; Brubaker RF
Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1285-93. PubMed ID: 2458330
[TBL] [Abstract][Full Text] [Related]
17. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
Retina; 1995; 15(2):134-40. PubMed ID: 7624601
[TBL] [Abstract][Full Text] [Related]
18. Blood-retinal and blood-aqueous barrier permeability, lens autofluorescence and transmission in insulin-dependent diabetic youngsters.
van Wirdum E; van Best J; Bruining GJ; de Beaufort C; Oosterhuis J
Graefes Arch Clin Exp Ophthalmol; 1989; 227(1):26-9. PubMed ID: 2920905
[TBL] [Abstract][Full Text] [Related]
19. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
[TBL] [Abstract][Full Text] [Related]
20. Fluorometric evaluation of panretinal photocoagulation in diabetic subjects.
Knudsen LL; Olsen T; Nielsen-Kudsk F
Acta Ophthalmol Scand; 1997 Aug; 75(4):393-7. PubMed ID: 9374246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
